Charles Schwab’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $415M | Sell |
1,063,288
-8,275
| -0.8% | -$3.5M | 0.06% | 278 |
|
|
2026
Q1 | $507M | Buy |
1,071,563
+2,853
| +0.3% | +$1.44M | 0.08% | 215 |
|
|
2025
Q4 | $499M | Sell |
1,068,710
-16,397
| -2% | -$7.61M | 0.08% | 212 |
|
|
2025
Q3 | $462M | Sell |
1,085,107
-42,229
| -4% | -$16.4M | 0.07% | 221 |
|
|
2025
Q2 | $432M | Sell |
1,127,336
-16,950
| -1% | -$6.11M | 0.07% | 225 |
|
|
2025
Q1 | $395M | Sell |
1,144,286
-4,757
| -0.4% | -$1.53M | 0.07% | 227 |
|
|
2024
Q4 | $345M | Buy |
1,149,043
+6,590
| +0.6% | +$2.3M | 0.06% | 248 |
|
|
2024
Q3 | $464M | Sell |
1,142,453
-25,408
| -2% | -$9.3M | 0.09% | 193 |
|
|
2024
Q2 | $375M | Buy |
1,167,861
+8,394
| +0.7% | +$2.73M | 0.07% | 234 |
|
|
2024
Q1 | $387M | Buy |
1,159,467
+32,917
| +3% | +$10.1M | 0.09% | 199 |
|
|
2023
Q4 | $305M | Buy |
1,126,550
+6,407
| +0.6% | +$1.58M | 0.08% | 228 |
|
|
2023
Q3 | $276M | Sell |
1,120,143
-6,925
| -0.6% | -$1.89M | 0.08% | 220 |
|
|
2023
Q2 | $342M | Sell |
1,127,068
-33,089
| -3% | -$9.2M | 0.1% | 182 |
|
|
2023
Q1 | $306M | Buy |
1,160,157
+13,613
| +1% | +$3.46M | 0.09% | 192 |
|
|
2022
Q4 | $275M | Buy |
1,146,544
+9,133
| +0.8% | +$2.05M | 0.09% | 213 |
|
|
2022
Q3 | $209M | Sell |
1,137,411
-24,135
| -2% | -$4.81M | 0.07% | 237 |
|
|
2022
Q2 | $195M | Sell |
1,161,546
-55,473
| -5% | -$11.9M | 0.07% | 265 |
|
|
2022
Q1 | $305M | Buy |
1,217,019
+31,199
| +3% | +$7.83M | 0.09% | 200 |
|
|
2021
Q4 | $305M | Sell |
1,185,820
-19,833
| -2% | -$4.85M | 0.09% | 196 |
|
|
2021
Q3 | $293M | Sell |
1,205,653
-179,311
| -13% | -$43.8M | 0.1% | 185 |
|
|
2021
Q2 | $286M | Buy |
1,384,964
+5,006
| +0.4% | +$1.02M | 0.1% | 186 |
|
|
2021
Q1 | $260M | Buy |
1,379,958
+51,309
| +4% | +$9.05M | 0.1% | 185 |
|
|
2020
Q4 | $219M | Buy |
1,328,649
+3,282
| +0.2% | +$480K | 0.09% | 209 |
|
|
2020
Q3 | $165M | Buy |
1,325,367
+22,217
| +2% | +$2.75M | 0.08% | 233 |
|
|
2020
Q2 | $126M | Sell |
1,303,150
-185,745
| -12% | -$19.3M | 0.06% | 285 |
|
|
2020
Q1 | $134M | Buy |
1,488,895
+3,723
| +0.3% | +$482K | 0.08% | 242 |
|
|
2019
Q4 | $220M | Sell |
1,485,172
-29,562
| -2% | -$3.97M | 0.12% | 165 |
|
|
2019
Q3 | $182M | Buy |
1,514,734
+18,169
| +1% | +$2.35M | 0.11% | 186 |
|
|
2019
Q2 | $202M | Sell |
1,496,565
-67,299
| -4% | -$8.51M | 0.12% | 156 |
|
|
2019
Q1 | $204M | Buy |
1,563,864
+194,524
| +14% | +$26.1M | 0.13% | 144 |
|
|
2018
Q4 | $170M | Buy |
1,369,340
+177,075
| +15% | +$23.8M | 0.13% | 144 |
|
|
2018
Q3 | $166M | Sell |
1,192,265
-30,078
| -2% | -$3.74M | 0.11% | 165 |
|
|
2018
Q2 | $125M | Buy |
1,222,343
+64,426
| +6% | +$6.52M | 0.09% | 203 |
|
|
2018
Q1 | $112M | Buy |
1,157,917
+31,209
| +3% | +$3.03M | 0.09% | 218 |
|
|
2017
Q4 | $99M | Buy |
1,126,708
+8,623
| +0.8% | +$693K | 0.08% | 241 |
|
|
2017
Q3 | $89M | Buy |
1,118,085
+51,727
| +5% | +$4.16M | 0.08% | 238 |
|
|
2017
Q2 | $93M | Buy |
1,066,358
+12,797
| +1% | +$1.08M | 0.09% | 227 |
|
|
2017
Q1 | $93.8M | Sell |
1,053,561
-30,231
| -3% | -$2.52M | 0.09% | 206 |
|
|
2016
Q4 | $80.2M | Buy |
1,083,792
+52,825
| +5% | +$3.96M | 0.09% | 222 |
|
|
2016
Q3 | $78M | Sell |
1,030,967
-6,589
| -0.6% | -$505K | 0.09% | 222 |
|
|
2016
Q2 | $79.9M | Buy |
1,037,556
+15,333
| +1% | +$1.21M | 0.1% | 203 |
|
|
2016
Q1 | $79.8M | Sell |
1,022,223
-5,282
| -0.5% | -$369K | 0.1% | 180 |
|
|
2015
Q4 | $69.5M | Buy |
1,027,505
+33,743
| +3% | +$2.35M | 0.09% | 205 |
|
|
2015
Q3 | $76.9M | Buy |
993,762
+50,337
| +5% | +$4.46M | 0.11% | 174 |
|
|
2015
Q2 | $85.6M | Buy |
943,425
+18,849
| +2% | +$1.51M | 0.12% | 168 |
|
|
2015
Q1 | $69.6M | Buy |
924,576
+409,902
| +80% | +$29.4M | 0.1% | 203 |
|
|
2014
Q4 | $37.8M | Buy |
514,674
+33,886
| +7% | +$2.38M | 0.06% | 328 |
|
|
2014
Q3 | $33.9M | Buy |
480,788
+44,931
| +10% | +$2.97M | 0.06% | 323 |
|
|
2014
Q2 | $24.6M | Buy |
435,857
+23,139
| +6% | +$1.22M | 0.04% | 418 |
|
|
2014
Q1 | $21.7M | Buy |
412,718
+48,973
| +13% | +$2.44M | 0.04% | 436 |
|
|
2013
Q4 | $17.4M | Buy |
363,745
+73,563
| +25% | +$3.4M | 0.03% | 476 |
|
|
2013
Q3 | $12.9M | Buy |
290,182
+38,351
| +15% | +$1.5M | 0.03% | 526 |
|
|
2013
Q2 | $9.3M | Buy |
+251,831
| New | +$9.74M | 0.02% | 613 |
|
Other funds holding HCA
Charles Schwab's HCA Position: Q2 2026 in Review
Charles Schwab reduced its HCA Healthcare (HCA) stake by 0.77% in Q2 2026, selling an estimated $3.5M and leaving 1,063,288 shares worth $415M. The position accounts for 0.06% of the portfolio, ranked #278.
Charles Schwab first reported a position in HCA in Q2 2013 and has held it in 53 quarters since. The position peaked at $507M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.
- Charles Schwab held 1,063,288 shares of HCA Healthcare worth $415M as of Q2 2026.
- Charles Schwab sold 8,275 HCA Healthcare shares in Q2 2026, an estimated $3.5M.
- HCA Healthcare made up 0.06% of Charles Schwab's portfolio in Q2 2026, its #278 holding.
- Charles Schwab first reported a position in HCA Healthcare in Q2 2013 and has held it in 53 quarters since.
- Charles Schwab's HCA Healthcare position peaked at $507M in Q1 2026.
- 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.
Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.